Pfizer Animal Health, 1040 Swabia Court, Research Triangle Park, NC 27703, USA.
Poult Sci. 2010 Jan;89(1):189-93. doi: 10.3382/ps.2009-00093.
Mass vaccination of poultry has advanced in recent years with field application of in ovo vaccination technologies in hatcheries worldwide. Working from a laboratory concept to a commercially available system within a matter of a decade, with subsequent full application to 90% of US broiler production a few years later, the commercial systems continue to be an area for study and continued understanding. Within the production setting, 2 methods to evaluate the types of equipment available for this technology were evaluated in this research. Utilizing a whole hatchery approach and paired testing in a field setting allowed for direct comparison of the 2 US-manufactured in ovo systems (Embrex Inovoject System and Intelliject). The results of the whole hatchery study showed an advantage for 1 system at d 18 and 19 transfer, with the Embrex Inovoject System showing as much as a 2.32% advantage in percentage of hatch. Paired testing showed a statistical difference in percentage of hatchability at d 18 of transfer favoring the Embrex Inovoject System but no difference at d 19 transfer. Differences in the 2 systems were additionally evaluated in terms of day of transfer and flock age.
近年来,随着禽胚内接种技术在全球孵化场的现场应用,禽类的大规模接种取得了进展。这项技术从实验室概念到商业化系统的发展仅用了十年时间,随后几年内,该系统在美国 90%的肉鸡生产中得到了全面应用。商业化系统仍然是研究和不断深入了解的领域。在生产环境中,本研究评估了两种评估该技术可用设备类型的方法。利用整个孵化场的方法和现场配对测试,可直接比较两种美国制造的禽胚内接种系统(Embrex Inovoject 系统和 Intelliject)。整个孵化场研究的结果表明,在第 18 天和第 19 天转移时,有一个系统具有优势,Embrex Inovoject 系统的孵化率优势高达 2.32%。配对测试显示,在第 18 天转移时,孵化率具有统计学上的差异,有利于 Embrex Inovoject 系统,但在第 19 天转移时没有差异。此外,还根据转移天数和鸡群年龄评估了这两个系统的差异。